↓ Skip to main content

Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study

Overview of attention for article published in BMC Cancer, August 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study
Published in
BMC Cancer, August 2011
DOI 10.1186/1471-2407-11-354
Pubmed ID
Authors

S Yousuf Zafar, Jennifer L Malin, Steven C Grambow, David H Abbott, Deborah Schrag, Jane T Kolimaga, Leah L Zullig, Jane C Weeks, Mona N Fouad, John Z Ayanian, Robert Wallace, Katherine L Kahn, Patricia A Ganz, Paul Catalano, Dee W West, Dawn Provenzale, the Cancer Care and Outcomes Research and Surveillance (CanCORS) Consortium

Abstract

We describe early dissemination patterns for first-line bevacizumab given for metastatic colorectal cancer treatment.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 6%
Unknown 16 94%

Demographic breakdown

Readers by professional status Count As %
Other 4 24%
Student > Ph. D. Student 4 24%
Student > Bachelor 3 18%
Professor > Associate Professor 2 12%
Professor 1 6%
Other 2 12%
Unknown 1 6%
Readers by discipline Count As %
Medicine and Dentistry 8 47%
Social Sciences 2 12%
Psychology 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Nursing and Health Professions 1 6%
Other 1 6%
Unknown 3 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2011.
All research outputs
#14,718,998
of 23,577,654 outputs
Outputs from BMC Cancer
#3,473
of 8,530 outputs
Outputs of similar age
#72,003
of 107,902 outputs
Outputs of similar age from BMC Cancer
#40
of 102 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,530 research outputs from this source. They receive a mean Attention Score of 4.4. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,902 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.